Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CFO Fawwad Qureshi sold 6,177 shares of the firm’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $22.18, for a total value of $137,005.86. Following the completion of the transaction, the chief financial officer owned 2,081 shares in the company, valued at $46,156.58. The trade was a 74.80% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Fawwad Qureshi also recently made the following trade(s):
- On Friday, February 27th, Fawwad Qureshi sold 2,837 shares of Trupanion stock. The shares were sold at an average price of $26.46, for a total value of $75,067.02.
Trupanion Price Performance
Shares of NASDAQ:TRUP traded down $0.17 during midday trading on Wednesday, hitting $21.69. The company had a trading volume of 371,901 shares, compared to its average volume of 428,641. Trupanion, Inc. has a twelve month low of $21.16 and a twelve month high of $57.88. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73. The stock has a market cap of $946.12 million, a price-to-earnings ratio of 36.76 and a beta of 1.49. The business’s 50-day simple moving average is $25.08 and its 200-day simple moving average is $30.52.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of TRUP. Federated Hermes Inc. purchased a new position in shares of Trupanion during the third quarter worth $33,000. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Trupanion during the third quarter worth $39,000. Parallel Advisors LLC boosted its position in shares of Trupanion by 1,831.9% during the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after buying an additional 1,722 shares during the period. Kemnay Advisory Services Inc. purchased a new position in shares of Trupanion during the fourth quarter worth $64,000. Finally, Kelleher Financial Advisors purchased a new position in shares of Trupanion during the third quarter worth $74,000.
Analyst Upgrades and Downgrades
TRUP has been the subject of several analyst reports. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Piper Sandler lowered their price objective on Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Stifel Nicolaus lowered their price objective on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a research report on Tuesday, March 31st. Bank of America lowered their price objective on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research report on Tuesday, April 14th. Finally, Cantor Fitzgerald lowered their price objective on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $42.25.
Get Our Latest Research Report on TRUP
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Stories
- Five stocks we like better than Trupanion
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
